Abingdon Health (LON:ABDX) Reaches New 1-Year High – Should You Buy?

Abingdon Health Plc (LON:ABDX)’s share price reached a new 52-week high on Wednesday . The stock traded as high as GBX 13 and last traded at GBX 12, with a volume of 4769792 shares changing hands. The stock had previously closed at GBX 11.75.

Abingdon Health Price Performance

The business’s fifty day moving average price is GBX 8.17 and its 200-day moving average price is GBX 7.11. The company has a market capitalization of £30.13 million, a P/E ratio of -14.81 and a beta of 0.12. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05.

Abingdon Health (LON:ABDX) last released its earnings results on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.